JPMORGAN CHASE & CO

Position in DMAC — DiaMedica Therapeutics Inc.

CIK 19617 NEW YORK, NY

Position in DMAC

as of Jun 30, 2026 · filed Aug 12, 2026 Compact

Position Value

$106,958

+$10,039 QoQ

Shares Held

15,193

+6.1% QoQ

Ownership

0.028%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#51

of 87 holders

Holding Since

Jun 2020

12 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

JPMORGAN CHASE & CO holds $12,920,143,243 across 425 Biotechnology names. DMAC ranks #269 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	6,517,600	$3,237,487,438
2	REGN	Regeneron Pharmaceuticals, Inc.	3,774,199	$2,353,364,036
3	INSM	INSMED Inc	10,428,170	$1,111,851,478
4	ALNY	Alnylam Pharmaceuticals, Inc.	2,675,517	$805,410,876
5	RVMD	Revolution Medicines, Inc.	3,298,066	$617,661,794
6	RYTM	Rhythm Pharmaceuticals, Inc.	2,652,746	$294,534,385
7	JAZZ	Jazz Pharmaceuticals plc	1,160,786	$279,714,596
8	QURE	uniQure N.V.	4,867,755	$224,208,791

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$106,958	15,193	+6.1%	Shares	Defined	2026-08-12
2026-03-31	$96,919	14,316	+5.6%	Shares	Defined	2026-05-13
2025-12-31	$107,928	13,559	+6.1%	Shares	Defined	2026-02-11
2025-09-30	$87,832	12,785	+2.4%	Shares	Defined	2025-11-07
2025-06-30	$48,683	12,483	+46133.3%	Shares	Defined	2025-08-12
2024-09-30	$113	27	-95.2%	Shares	Defined	2024-12-26
2023-12-31	$1,601	564	+2156.0%	Shares	Defined	2024-12-26
2023-09-30	$64	25	+19.0%	Shares	Defined	2023-11-14
2023-06-30	$90	21	-99.7%	Shares	Defined	2023-08-11
2021-06-30	$36,930	8,299	+103637.5%	Shares	Defined	2021-08-12
2020-09-30	$33	8	0.0%	Shares	Defined	2020-11-12
2020-06-30	$55	8	—	Shares	Defined	2020-08-11
No filing history on record for this holder in this stock.